AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25757214 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control group)
Number of subjects: 202
Study 25224665 — intervention group
Group type: EXPERIMENTAL
Intervention: docetaxel-based chemotherapy + zoledronic acid (ZA)
Number of subjects: 105
Study 25224665 — intervention group
Group type: COMPARATOR
Intervention: docetaxel-based chemotherapy + placebo
Number of subjects: 105
Study 22583028 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 121
Study 22583028 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention plus incentive
Number of subjects: 121
Study 20664163 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling shirt (mild cooling)
Number of subjects: 0
Study 20664163 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice vest (strong cooling)
Number of subjects: 0
Study 17442125 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (CBT) for PTSD, conducted over a 5-week period (10 sessions)
Number of subjects: 96
Study 17442125 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive behavioural therapy (CBT) for PTSD
Number of subjects: 96
Study 17442125 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 96
Study 16450851 — intervention group
Group type: EXPERIMENTAL
Intervention: New experimental treatment
Number of subjects: 0
Study 16450851 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16450851 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 0
Study 12466029 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD)
Number of subjects: 13
Study 12466029 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine/phenylalanine depletion (TPD)
Number of subjects: 13
Study 12466029 — intervention group
Group type: COMPARATOR
Intervention: Balanced control condition (B)
Number of subjects: 13
Study 9280026 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia
Number of subjects: 54
Study 9280026 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural analgesia
Number of subjects: 54
Study 8435991 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive dietary and exercise education
Number of subjects: 83
Study 8435991 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment given by community health centres (conventionally treated group)
Number of subjects: 83
Study 8435991 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group with declining fasting blood glucose (n = 39)
Number of subjects: 83
Study 8435991 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group with no change or increase in blood glucose level (n = 44)
Number of subjects: 83
Study 3534631 — intervention group
Group type: EXPERIMENTAL
Intervention: Indenolol
Number of subjects: 0
Study 3534631 — intervention group
Group type: COMPARATOR
Intervention: Orciprenaline test
Number of subjects: 0
Study 28905166 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help treatment including three motivational telephone interviews and a cognitive-behavioral self-help workbook
Number of subjects: 62
Study 28905166 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help treatment
Number of subjects: 62
Study 28905166 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group)
Number of subjects: 62
Study 23893066 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) component of the depression prevention program 'Op Volle Kracht' (OVK), 8 lessons
Number of subjects: 102
Study 23893066 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 102
Study 23893066 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) component of OVK
Number of subjects: 102
Study 22074913 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-row technique
Number of subjects: 52
Study 22074913 — intervention group
Group type: COMPARATOR
Intervention: Suture-bridge technique
Number of subjects: 52
Study 20440520 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclo + mtx (cyclosporin at 7.5 mg/kg/day for 6 weeks, then 4 mg/kg/day + methotrexate at 5 mg/kg/week for 1 year)
Number of subjects: 17
Study 20440520 — intervention group
Group type: COMPARATOR
Intervention: Control (standard insulin therapy)
Number of subjects: 17
Study 20440520 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclo + mtx
Number of subjects: 17
Study 17563342 — intervention group
Group type: EXPERIMENTAL
Intervention: HiMF training (HiMFT)
Number of subjects: 55
Study 17563342 — intervention group
Group type: EXPERIMENTAL
Intervention: LoMF training (LoMFT)
Number of subjects: 55
Study 17563342 — intervention group
Group type: COMPARATOR
Intervention: HiMF control
Number of subjects: 55
Study 17563342 — intervention group
Group type: COMPARATOR
Intervention: LoMF control
Number of subjects: 55
Study 16249142 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband blue light treatment (8 sessions of 10- or 20-minute treatments over 4 weeks)
Number of subjects: 30
Study 16249142 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrowband blue light treatment
Number of subjects: 30
Study 12177624 — intervention group
Group type: EXPERIMENTAL
Intervention: T‐tube removal with contemporary placement of a counter‐drain under fluoroscopic guidance (group 1)
Number of subjects: 145
Study 12177624 — intervention group
Group type: COMPARATOR
Intervention: T‐tube removal without counter‐drain (group 2)
Number of subjects: 145
Study 10190617 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple ganglion aspiration
Number of subjects: 0
Study 10190617 — intervention group
Group type: COMPARATOR
Intervention: Aspiration and multiple puncture
Number of subjects: 0
Study 8524722 — intervention group
Group type: EXPERIMENTAL
Intervention: Community organization promotional activities (including physician reminders, wallet cards, newspaper ads)
Number of subjects: 2
Study 8524722 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician office staff encouragement
Number of subjects: 2
Study 8524722 — intervention group
Group type: EXPERIMENTAL
Intervention: Display board
Number of subjects: 2
Study 8524722 — intervention group
Group type: COMPARATOR
Intervention: Promotional activities
Number of subjects: 2
Study 1959800 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin III concentrate administration during surgery
Number of subjects: 25
Study 1959800 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study 6115807 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 100 mg, taken twice a day
Number of subjects: 168
Study 6115807 — intervention group
Group type: COMPARATOR
Intervention: Placebo, taken twice a day
Number of subjects: 168
Study 30819464 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation Planning
Number of subjects: 14
Study 30819464 — intervention group
Group type: EXPERIMENTAL
Intervention: Role Play
Number of subjects: 14
Study 30819464 — intervention group
Group type: EXPERIMENTAL
Intervention: Participant Modeling
Number of subjects: 14
Study 30819464 — intervention group
Group type: EXPERIMENTAL
Intervention: Raising Awareness
Number of subjects: 14
Study 30819464 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Consulting
Number of subjects: 14
Study 30819464 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation supports (overall)
Number of subjects: 14
Study 28950351 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB (carboplatin, paclitaxel, and bevacizumab)
Number of subjects: 153
Study 28950351 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB plus cixutumumab 6 mg/kg i.v. weekly
Number of subjects: 153
Study 28950351 — intervention group
Group type: COMPARATOR
Intervention: Control group (historical controls)
Number of subjects: 153
Study 26528705 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan plus Cyclophosphamide
Number of subjects: 21
Study 24667090 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition-education program
Number of subjects: 1143
Study 23139763 — intervention group
Group type: EXPERIMENTAL
Intervention: -110°C whole body cryotherapy (WBC)
Number of subjects: 20
Study 23139763 — intervention group
Group type: COMPARATOR
Intervention: 8°C cold water immersion (CWI)
Number of subjects: 20
Study 19337788 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel therapy
Number of subjects: 92
Study 19337788 — intervention group
Group type: COMPARATOR
Intervention: Control group with matching ethnic composition
Number of subjects: 92
Study 17473847 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 3408
Study 17473847 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 3408
Study 17473847 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 3408
Study 17473847 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 3408
Study 15717138 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 15
Study 15717138 — intervention group
Group type: COMPARATOR
Intervention: Losartan-placebo
Number of subjects: 15
Study 15717138 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute TD-GTN 20 mg
Number of subjects: 15
Study 11443170 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 18
Study 11443170 — intervention group
Group type: COMPARATOR
Intervention: Control (rhGH only)
Number of subjects: 18
Study 10052878 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilization of the legs with an alpha-cradle system (Group B)
Number of subjects: 52
Study 10052878 — intervention group
Group type: COMPARATOR
Intervention: Immobilization at the pelvis level with an alpha-cradle system (Group A)
Number of subjects: 52
Study 10052878 — intervention group
Group type: COMPARATOR
Intervention: Previously investigated non-immobilized patients
Number of subjects: 52
Study 7976150 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression models based on the APACHE II-system
Number of subjects: 952
Study 7976150 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of the TISS score
Number of subjects: 952
Study 7976150 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical models
Number of subjects: 952
Study 7976150 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk patients
Number of subjects: 952
Study 2505641 — intervention group
Group type: EXPERIMENTAL
Intervention: Central venous pressure monitoring catheter (Group I)
Number of subjects: 226
Study 2505641 — intervention group
Group type: COMPARATOR
Intervention: Conventional pulmonary artery catheter (Group II)
Number of subjects: 226
Study 2505641 — intervention group
Group type: COMPARATOR
Intervention: Mixed venous oxygen saturation measuring PA catheter (Group III)
Number of subjects: 226
Study 2505641 — intervention group
Group type: COMPARATOR
Intervention: Conventional PA catheter (Group IV)
Number of subjects: 226
Study 2505641 — intervention group
Group type: COMPARATOR
Intervention: SvO2 measuring PA catheter (Group V)
Number of subjects: 226
Study 45573 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding bicarbonate or Lactobacilli to feeds
Number of subjects: 0
Study 45573 — intervention group
Group type: COMPARATOR
Intervention: Bottle-fed infants without intervention
Number of subjects: 0
Study 31286744 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 31286744 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture
Number of subjects: 0
Study 28720147 — intervention group
Group type: EXPERIMENTAL
Intervention: qHPV vaccine
Number of subjects: 129
Study 28720147 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 26055927 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vancomycin 125mg every 6 hours for 10 days
Number of subjects: 15
Study 23764999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient visual information available during haptic scene exploration
Number of subjects: 0
Study 23764999 — intervention group
Group type: COMPARATOR
Intervention: Blindfolded during haptic scene exploration
Number of subjects: 0
Study 23764999 — intervention group
Group type: EXPERIMENTAL
Intervention: Geometric information about a surrounding (virtual) room
Number of subjects: 0
Study 23764999 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient visual information in early stages of the task
Number of subjects: 0
Study 23764999 — intervention group
Group type: COMPARATOR
Intervention: Novel environment (Experiment 3)
Number of subjects: 0
Study 22282729 — intervention group
Group type: EXPERIMENTAL
Intervention: GBR + BS group (bone substitute plus a resorbable barrier)
Number of subjects: 80
Study 22282729 — intervention group
Group type: COMPARATOR
Intervention: GBR group (resorbable barrier alone)
Number of subjects: 80
Study 19239555 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% adenosine lotion
Number of subjects: 30
Study 19239555 — intervention group
Group type: COMPARATOR
Intervention: Placebo lotion
Number of subjects: 30
Study 16317012 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin (5000 IU)
Number of subjects: 439
Study 16317012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439
Study 14585873 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual dose of rFSH (100-250 IU/day)
Number of subjects: 267
Study 14585873 — intervention group
Group type: COMPARATOR
Intervention: Standard dose of rFSH (150 IU/day)
Number of subjects: 267
Study 10992823 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia
Number of subjects: 30
Study 10992823 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane anaesthesia
Number of subjects: 30
Study 8840821 — intervention group
Group type: EXPERIMENTAL
Intervention: PGWB
Number of subjects: 60
Study 8840821 — intervention group
Group type: EXPERIMENTAL
Intervention: PGWB-R
Number of subjects: 60
Study 8840821 — intervention group
Group type: EXPERIMENTAL
Intervention: PGWB and PGWB-R
Number of subjects: 60
Study 8840821 — intervention group
Group type: COMPARATOR
Intervention: GSRS
Number of subjects: 60
Study 1575558 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient enriched 'post‐discharge' milk formula
Number of subjects: 32
Study 1575558 — intervention group
Group type: COMPARATOR
Intervention: Standard term formula
Number of subjects: 32
Study 2857910 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine 2% (50 ml instilled before catheter removal)
Number of subjects: 78
Study 2857910 — intervention group
Group type: COMPARATOR
Intervention: Control (catheter removed after urethral catheterisation)
Number of subjects: 78
Study 2857910 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine intervention introduction
Number of subjects: 78
Study 30805708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cement augmentation of PHILOS screws (augmented group)
Number of subjects: 67
Study 30805708 — intervention group
Group type: COMPARATOR
Intervention: PHILOS screws without cement augmentation (control group)
Number of subjects: 67
Study 29596869 — intervention group
Group type: EXPERIMENTAL
Intervention: Active training group (approach-avoidance training for unhealthy food cues)
Number of subjects: 189
Study 29596869 — intervention group
Group type: COMPARATOR
Intervention: Sham training group (received sham training for both picture types)
Number of subjects: 189
Study 29596869 — intervention group
Group type: EXPERIMENTAL
Intervention: Active training group
Number of subjects: 189
Study 29596869 — intervention group
Group type: COMPARATOR
Intervention: Sham training group
Number of subjects: 189
Study 26284453 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary-intervention (SIT, n = 8)
Number of subjects: 16
Study 26284453 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control (CON, n = 8)
Number of subjects: 16
Study 25249560 — intervention group
Group type: EXPERIMENTAL
Intervention: Seattle Angina Questionnaire (SAQ)
Number of subjects: 917
Study 25249560 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in SAQ angina frequency scores from day 1 to week 8
Number of subjects: 917
Study 23095223 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational module training for nurse aide students
Number of subjects: 0
Study 20977033 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapeutic cognitive‐behavioral program including exposure technique (n = 28)
Number of subjects: 53
Study 20977033 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapeutic cognitive‐behavioral program with communication skills training (n = 25)
Number of subjects: 53
Study 18405161 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 22
Study 18405161 — intervention group
Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 22
Study 16087956 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential chemoradiotherapy (induction CT with cisplatin 120 mg/m2 on days 1, 29, and 57; vinorelbine 30 mg/m2/wk from day 1 to day 78; followed by thoracic RT at 66 Gy in 33 fractions)
Number of subjects: 205
Study 16087956 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy (RT started on day 1 with two cycles of cisplatin 20 mg/m2/d and etoposide 50 mg/m2/d; consolidation therapy with cisplatin 80 mg/m2 on days 78 and 106; vinorelbine 30 mg/m2/wk from days 78 to 127)
Number of subjects: 205
Study 12593422 — intervention group
Group type: EXPERIMENTAL
Intervention: 123I-BMIPP SPECT
Number of subjects: 34
Study 12593422 — intervention group
Group type: COMPARATOR
Intervention: 201Tl SPECT
Number of subjects: 34
Study 12593422 — intervention group
Group type: COMPARATOR
Intervention: PYP/Tl dual-isotope SPECT
Number of subjects: 34
Study 10510168 — intervention group
Group type: EXPERIMENTAL
Intervention: morphology and morphometry analysis of the pars opercularis using MRI
Number of subjects: 108
Study 7577293 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized lignocaine
Number of subjects: 6
Study 7577293 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 6
Study 1774421 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 61
Study 1774421 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 61
Study 1774421 — intervention group
Group type: EXPERIMENTAL
Intervention: L-deprenyl
Number of subjects: 61
Study 1774421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 7054041 — intervention group
Group type: EXPERIMENTAL
Intervention: Golytely
Number of subjects: 20
Study 7054041 — intervention group
Group type: COMPARATOR
Intervention: Standard prep
Number of subjects: 20
Study 31106905 — intervention group
Group type: EXPERIMENTAL
Intervention: pH 4 water-in-oil emulsion
Number of subjects: 20
Study 31106905 — intervention group
Group type: COMPARATOR
Intervention: pH 5.8 water-in-oil emulsion
Number of subjects: 20
Study 31106905 — intervention group
Group type: EXPERIMENTAL
Intervention: pH 4 water-in-oil emulsion after SDS challenge
Number of subjects: 20
Study 28765136 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD-web (interactive web page for self-management)
Number of subjects: 0
Study 28765136 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 25854537 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 0
Study 23967189 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention focusing on experimental control and base rate consideration
Number of subjects: 0
Study 23967189 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention before task)
Number of subjects: 0
Study 21856044 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibial intraosseous access
Number of subjects: 182
Study 21856044 — intervention group
Group type: COMPARATOR
Intervention: Humeral intraosseous access
Number of subjects: 182
Study 21856044 — intervention group
Group type: COMPARATOR
Intervention: Peripheral intravenous access
Number of subjects: 182
Study 19910828 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated exercise condition (5 sets of arm curls using dumbbells at 70% isometric maximal voluntary contraction until failure on days 1, 2, 3, and 5 of recovery)
Number of subjects: 12
Study 19910828 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no treatment applied)
Number of subjects: 12
Study 16492823 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 14
Study 16492823 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 14
Study 15329509 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10-20 mg) plus diet
Number of subjects: 8009
Study 15329509 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 8009
Study 11036801 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (DEX)
Number of subjects: 73
Study 11036801 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 73
Study 11036801 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 73
Study 9283055 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valeranate 10 mg (E)
Number of subjects: 55
Study 9283055 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valeranate 4 mg plus prasterone enantate 200 mg (E+P)
Number of subjects: 55
Study 9283055 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 55
Study 8510192 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (nicotine gum)
Number of subjects: 38
Study 8510192 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 38
Study 3305207 — intervention group
Group type: COMPARATOR
Intervention: Monthly maintenance chemotherapy for 2 years (Group A)
Number of subjects: 269
Study 3305207 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly maintenance chemotherapy plus viral oncolysate injection on day 15 (Group A+IT)
Number of subjects: 269
Study 3305207 — intervention group
Group type: COMPARATOR
Intervention: Maintenance chemotherapy after early consolidation
Number of subjects: 269
Study 3305207 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation only after early consolidation
Number of subjects: 269
Study 31668996 — intervention group
Group type: EXPERIMENTAL
Intervention: BIPOLIFE® (serious game)
Number of subjects: 41
Study 31668996 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 41